The single-agent antipyretic analgesic ‘acetaminophen’ recorded the largest-ever sales in outpatient prescriptions.

The prescription market for acetaminophen has increased significantly due to the unceasing number of confirmed COVID-19 cases arising despite the end of the COVID-19 pandemic and the increase in flu and cold patients. The rise in the insurance drug price of acetaminophen the government made to stabilize acetaminophen supply has also contributed to the market expansion.

According to the market research institution UBIST, the outpatient prescription market for single-agent acetaminophen drugs in Q2 was KRW 14.1 billion, up 89.2% YoY. The increase in the prescription